Skip to main content
Medical information Clinical review pending

Genetic Testing

Keap1 Gene Goitre Multinodular Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the KEAP1 gene associated with multinodular goitre. Helps understand hereditary risks for goitre.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Saliva sample. Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is typically required. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Keap1 Gene Goitre Multinodular Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of goitre or thyroid disorders.
  • ✓Symptoms suggestive of goitre (e.g., neck swelling, difficulty swallowing).
  • ✓Individuals seeking to understand genetic predisposition to goitre.
  • ✓Patients with known risk factors for endocrine disorders.
02

In plain language

What this test helps you understand

Identifies genetic mutations in the KEAP1 gene associated with multinodular goitre, aiding in understanding hereditary risks and potentially guiding management strategies.
The Keap1 Gene Goitre Multinodular NGS Genetic DNA Test is a diagnostic tool using Next Generation Sequencing (NGS) technology to assess genetic predispositions to multinodular goitre. This test helps identify individuals at risk for goitre-related disorders, which can be linked to genetic factors. Understanding your genetic makeup can empower you in making informed health decisions. This test specifically detects mutations in the KEAP1 gene, associated with goitre and other endocrine disorders. By analyzing your DNA, the test can reveal genetic variants that may increase your likelihood of developing goitre. Results will indicate whether any mutations were detected. A genetic counselor can help interpret the results and discuss potential implications for your health and family.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required. Confirm with the laboratory before booking.
SampleBlood sample (EDTA tube) or Saliva sample. Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) of the KEAP1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific mutations in the KEAP1 gene. It does not detect all possible genetic causes of goitre. Results should be interpreted in conjunction with clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test uses advanced DNA sequencing technology to look for specific genetic changes (mutations) in the KEAP1 gene that are linked to an increased risk of developing multinodular goitre.
Individuals with a family history of goitre, those experiencing symptoms like neck swelling, or anyone concerned about their genetic risk for goitre may consider this test.
The test specifically analyzes the KEAP1 gene for mutations associated with multinodular goitre and related endocrine conditions.
Results indicate the presence or absence of specific KEAP1 gene mutations. A genetic counselor can help explain the results and their potential implications for your health and family.
Generally, no special preparation is required. However, it is best to confirm specific instructions with the laboratory before your appointment.
We have laboratory branches in major cities like Nairobi, Mombasa, and Kisumu, and offer home sample collection services. Contact us to book.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp